Clinical audit of current Helicobacter pylori treatment outcomes in Singapore

Clinical audit of current Helicobacter pylori treatment outcomes in Singapore

Introduction: H. pylori eradication reduces the risk of gastric malignancies and peptic ulcer disease. First-line therapies include 14-day PAC (proton pump inhibitor [PPI], amoxicillin, clarithromycin) and PBMT (PPI, bismuth, metronidazole, tetracycline). Second-line therapies include 14-day PBMT an...

Full description

Saved in:
Bibliographic Details
Main Authors: Tiing Leong Ang, Kim Wei Lim, Daphne Ang, Yu Jun Wong, Malcolm Tan, Andrew Siang Yih Wong
Format: Article
Language:English
Published: Wolters Kluwer – Medknow Publications 2022-09-01
Series:Singapore Medical Journal
Subjects:
first line treatment
helicobacter pylori
second line treatment
Online Access:https://journals.lww.com/10.11622/smedj.2021105
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.lww.com/10.11622/smedj.2021105

Similar Items